Skip to content

Preconception and Pregnancy Obesity Treatment and Prevention Among Women With a History of Depression

Preconception and Pregnancy Obesity Treatment and Prevention Among Women With a History of Depression

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03053323
Enrollment
24
Registered
2017-02-15
Start date
2017-02-17
Completion date
2023-12-01
Last updated
2025-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Preconception, Pregnancy, Lifestyle

Brief summary

The purpose of the Preconception and Pregnancy Obesity Treatment and Prevention Among Women with A History of Depression preliminary study is to provide a lifestyle intervention for women with a history of depression who are trying to conceive or are pregnant in order to prevent excessive pre-pregnancy weights, avoid excessive gestational weight gain, and to improve other markers of metabolic health. The treatment program consists of 10 private sessions with a trained clinician at no cost to participants.

Detailed description

The investigators are evaluating a new lifestyle intervention to help women with a history of depression who are pregnant or trying to conceive to learn to exercise, eat well, and live a healthy lifestyle. They are interested in examining if this therapy-based program can positively impact eating and exercising habits and see if the treatment is enjoyable. All participants will receive this intervention.

Interventions

BEHAVIORALLifestyle Intervention

The lifestyle intervention consists of three components: nutrition, physical activity, and other areas of wellness. The intervention is administered individually each week for 10 weeks and is tailored for women with a history of depression who are in the first trimester of pregnancy or trying to conceive.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* History of depression * Pregnant in first trimester or planning to become pregnant within next year * Ability to give informed consent * Age \> or = 18 and \< 45 years * Overweight or obese (Body mass index \> 25 kg/m\^2)

Exclusion criteria

* Unwilling/unable to comply with study procedures * Endorsed item on the Physical Activity Readiness Questionnaire (PAR-Q) * Diagnosis of anorexia nervosa or bulimia nervosa in the past month * Diagnosis of substance dependence in the past month * Active suicidality (Montgomery Asberg Depression Rating Scale (MADRS) item 10 score \> 4) * Exercising regularly (i.e., 5 days per week for 30 min) * Neurologic disorder or history of head trauma * Contraindications to exercise or diet interventions (e.g., co-morbid nutritional and metabolic diseases, physical injuries, contraindications to exercise for pregnant women)

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of treatment measured by participation rates10 weeksParticipation rates measure attendance at weekly sessions.
Acceptability of treatment on Client Satisfaction Questionnaire (CSQ-8)10 weeksThe CSQ-8 is a reliable and valid self-report measure of satisfaction with care and perceived quality and acceptability of treatment.

Secondary

MeasureTime frameDescription
Weight loss10 weeksWeight will be measured during pre-, mid-, and post-treatment visits.
Exercise duration on the Exercise Questionnaire (EQ)10 weeksThe EQ assesses baseline exercise history and ongoing exercise duration and frequency.
Depression severity on the Montgomery-Asberg Depression Rating Scale (MADRS)10 weeksThe MADRS assesses the presence and severity of patient's current depressive symptoms.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026